{"disease":{"id":"btk-degraders","name":"btk degraders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07099443","title":"Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Nantes University Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}